SAINT BELLA GROUP LIMITED released a profit alert indicating a strong first-half performance for the six months ended 30 June 2026.

Revenue and Profitability • Revenue is expected to reach not less than RMB 608.00 million, at least 35% higher than the same period in 2025. • Adjusted net profit is set to exceed RMB 60.00 million, representing growth of no less than 54% year on year. • Statutory net profit is projected at a minimum of RMB 53.40 million, versus RMB 326.90 million in the prior-year period, which had been boosted by a one-off RMB 318.20 million fair-value gain on financial instruments. With that non-cash item no longer recurring post-listing, the current figures better reflect underlying operations.

Growth Drivers 1. Revenue mix enhancement: Higher average customer spending and firm demand for core postpartum centre services, coupled with strong take-up of value-added offerings such as rehabilitation care, home-visit services and health & wellness products, lifted overall topline performance. 2. Dual-engine expansion: Continued organic network growth and the completion of the 22 June 2026 acquisition of Wuhan-based maternity brand “Fu Lei Ya” supported scale expansion, while disciplined cost control reduced selling and administrative expense ratios, bolstering profitability. 3. “AI + Care” integration: Deployment of the in-house large language model “Dr. Bella” across in-store and home-visit services improved staff productivity and trimmed marketing and administrative costs. Initial commercialisation of AI agents generated new revenue streams and contributed to profit growth.

Capital-Market Actions The company reiterated its commitment to enhancing shareholder value through periodic share repurchases and continued investment in its full-cycle service matrix.

SAINT BELLA plans to publish its detailed unaudited interim results before end-August 2026. Investors are advised to exercise caution when dealing in the company’s securities until the formal results announcement is released.